Search results for: Jimena Ferraro
Filter search results
OHE is Pleased to Announce the Appointment of Two New Economists: Margherita Neri and Jimena Ferraro
14 February 2017
Margherita Neri and Jimena Ferraro joined the OHE team in December 2016 and January 2017, respectively. We welcome them to the team. Margherita Neri joined the OHE team in December…
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
…Ferraro, Phill O’Neill and Adrian Towse. Read the full report here. Citation Ferraro, J. S., O’Neill, P. & Towse, A. 2018. Measurement of Medicines Expenditure in the Context of the…
G7 Investments in New Antibiotics Would Pay Off – For Everyone
9 December 2022
…of Health Economics Research Paper, May 2017 Available at: https://www.ohe.org/news/assessing-value-new-antibiotics-additional-elements-value-health-technology-assessment Ferraro, J., Towse, A., and Mestre-Ferrandiz J. Incentives for New Drugs to Tackle Anti-Microbial Resistance. Office of Health Economics Research…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…per QALY gained. Draft guidelines are expected to be published for consultation in the week of 15th June 2020. The new model, presented in a forthcoming OHE paper (Berdud, Ferraro and Towse, 2020),…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…recognise data barriers underlying current supply-side estimates, and to be receptive to new approaches. One new approach will be presented in a forthcoming OHE research paper where Berdud, Ferraro and…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…Missing a Central Role for HTA and Value Assessment. OHE Research Paper, London: Office of Health Economics. Berdud, M., Chalkidou, K., Dean, E., Ferraro, J., Garrison, L., Nemzoff, C. and…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…and Towse, A., 2019. HTA and payment mechanisms for new drugs to tackle AMR. OHE Research Paper, London: Office of Health Economics. Available at: https://www.ohe.org/publications/hta-and-payment-mechanisms-new-drugs-tackle-amr Ferraro, J., Towse, A. and…
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
7 October 2019
…Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions. OHE Briefing. Office of Health Economics: London. RePEc. Ferraro, J., Towse, A., and Mestre-Ferrandiz, J.,…
OHE Presents at Global AMR R&D Hub Board of Members Meeting in Paris
18 December 2019
…Economics. RePEc. Ferraro, J., Towse, A. and Mestre-Ferrandiz, J., 2017. Incentives for New Drugs to Tackle Anti-Microbial Resistance. OHE Briefing. London: Office of Health Economics. RePEc. Karlsberg Schaffer, S., West,…